“Prevention is better than cure” – a phrase that serves as a guiding principle in many cultures. For women aiming to live high-performance lives, it is more than just a saying: it is a system. Early detection transforms uncertainty into strategy, reduces risks, and preserves what drives performance: energy, clarity, and health.

Early detection means identifying health risks before symptoms occur – to simplify treatments, improve prognoses, and ensure quality of life. Three foundational elements are central: genetic risk assessment, targeted gynecological screening strategies, and the maintenance of bone health. Those with a family history of breast or ovarian cancer should consider screening for BRCA mutationshereditary changes in BRCA1/BRCA2 that impair DNA repair processes and significantly increase cancer risk. Women with an increased risk of gynecological cancers benefit from more closely spaced examinations, such as clinical breast exams, imaging, or – depending on risk – specialized screening procedures. Concurrently, vitamin D status is relevant: 25-hydroxyvitamin Dblood value reflecting the vitamin D status regulates bone mineralization together with calcium and affects muscle function and metabolism. The goal is not a test marathon but a personalized, streamlined program that reduces risks where they are real – and protects performance in the long term.

Those who know their genetic predisposition make better decisions. In an analysis of breast cancer patients, knowledge of BRCA1/2 alterations led to adjusted care in the vast majority, influencing therapy and prevention within families ^[1]. For women at increased risk, more intensive gynecological check-ups can be a less invasive alternative to pharmacological prevention or prophylactic surgery – and willingness to participate can be significantly increased through structured education ^[2]. At the same time, optimal vitamin D status is a cornerstone for strong bones and stable muscles; deficiency promotes bone substance loss, muscle weakness, and increases fracture risk, particularly in older and postmenopausal women ^[3]. Position papers show: deficiencies are widespread, diagnosed via the 25-OH-D level, and should be specifically addressed in cases of deficiency, ideally alongside adequate calcium intake to support bone health and fall prevention ^[4]. Surprisingly for many: even in sunny regions like India, women are often inadequately supplied, especially with low sun exposure and low calcium intake – a clear indication not to underestimate the status ^[5].

A retrospective cohort analysis of breast cancer patients with known germline status showed that the discovery of pathogenic BRCA1/2 variants significantly increases probabilities based on clinical risk criteria; notably, family history and triple-negative breast cancer were strong predictors. Remarkably, in almost 87% of cases, the test results led to changes in clinical management – an immediate practical benefit for therapy decisions and predictive measures within families ^[1]. Prospective observations and clinical consultation concepts in high-risk cohorts have shown that more intensive, risk-adapted early detection programs are widely accepted and present a realistic, less invasive strategy compared to chemoprevention or prophylactic interventions. After structured counseling, the regular use of recommended methods measurably increased ^[2]. For bone health, the synthesis of observational and interventional data shows: vitamin D deficiency is reliably determined via 25-OH-D; severe deficiencies are associated with low bone density and higher fracture risk. Intervention studies suggest that supplementation in maintenance doses – after correcting the deficiency – combined with adequate calcium, benefits skeletal integrity, while effects on non-skeletal endpoints remain heterogeneous ^[4]. The physiological role of vitamin D for calcium homeostasis and neuromuscular function is well-documented; ongoing research aims to establish clear thresholds and optimal dosages for different population groups ^[3].

- Assess your hereditary risk: If there is a family history of breast or ovarian cancer, seek medical advice on BRCA1/2 testing; results can specifically change therapy and prevention decisions for you and your relatives ^[1].
- Establish risk-adapted screening: If there is an increased risk of gynecological cancer, plan for more frequent and targeted examinations (e.g., clinical breast exam, mammography/MRI as per guidelines, transvaginal ultrasound, Pap/HPV test) in consultation with specialists; structured counseling increases effective participation ^{[2] [6]}.
- Measure vitamin D status: Have your 25-OH-D vitamin D level assessed – especially at northern latitudes, with low sun exposure, or darker skin – and correct deficiencies specifically ^{[4] [5]}.
- Implement supplementation smartly: After a medical correction strategy, switch to maintenance doses (typically 800–2000 IU/day) and ensure adequate calcium intake (about 1000–1200 mg/day through diet) to strengthen bones and muscles ^{[4] [3]}.
- Optimize daily life: Schedule daily short sun exposure windows (consider skin type and season), prioritize calcium-rich foods (e.g., fermented dairy products, green vegetables, fortified alternatives), and integrate strength training 2–3 times a week – for strong bones, better posture, and injury prevention ^{[3] [4]}.

Early detection is a performance tool: Assess your genetic risk, implement risk-adapted checks, and secure your vitamin D status. Small, precise steps today prevent big problems tomorrow. Start this week by scheduling an appointment for counseling and a blood test – your future will thank you.